Logo of AYYAN Investment Co.
AYYAN Investment Co. determined the period of its rights issue trading and subscription to the new shares, according to a statement to Tadawul today, July 10.
Both will start on July 14. However, rights issue trading will end on July 21, while the period for subscription to new shares will expire on July 21, the statement indicated.
Right-holders may exercise their subscription right, in whole or in part, to the new shares in proportion to the rights existing in their portfolios. For registered shareholders and new investors, rights trading and new shares subscription will be as per the prospectus.
Any unsubscribed shares and fractional shares will be offered to institutional investors, in accordance with the details set in the prospectus. Wasatah Capital will underwrite the new shares that remain unsubscribed after the rump offering.
The company also drew attention of investors not willing to subscribe to the importance of selling the rights issue they hold during the specified trading period to avoid the resulting decline in the value of their investment portfolios as a result of not benefiting from their rights, whether by way of sale or subscription.
According to data compiled by Argaam, AYYAN shareholders approved, on July 8, the board’s recommendation to increase capital via a SAR 200 million rights issue.
Capital Increase Details |
|
Current Capital |
SAR 806.36 mln |
Number of Shares |
80.64 mln |
New Capital |
SAR 1.006 bln |
Number of Shares |
100.64 mln |
Percentage of Capital Increase |
24.80% |
Rights Issue Details |
||
Offered Shares |
20 mln |
|
Offer Price |
SAR 10 |
|
Issue Size |
SAR 200 mln |
|
Eligibility Ratio |
Each listed shareholder is entitled to subscribe to 0.2480 rights per share held |
|
Offering Proceeds (SAR mln) |
Purchase of medical devices and equipment for Al-Salam Hospital, affiliated with Al-Salam Medical Services Co. (a subsidiary) |
20.0 |
Payment to suppliers of subsidiary companies (Al Ahsa Medical Services and Al-Salam Medical Services) |
61.1 |
|
Payment of outstanding obligations to financial entities by its subsidiary Al-Salam Medical Services |
45 |
|
Payment of operational expenses for its subsidiary Al-Salam Medical Services |
67.9 |
|
Offering costs |
6.0 |
|
Total |
200 |
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}